Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.
8+Product Categories
500+Product Variants
MultipleDosage Forms
GMPQuality Sourced
Sterile injectable formulations for institutional and hospital requirements.
Beta-Lactam and Non-Beta-Lactam formulations across therapeutic categories.
Hard-shell capsule formulations in multiple strengths and compositions.
Paediatric and adult oral liquid and dry-syrup formulation options.
Creams, ointments and other topical dosage-form requirements.
Formulations supporting diabetes-management sourcing requirements.
Cardiovascular formulations across common dosage forms and strengths.
Page 1 of 2
Tablet
Amlodipine 5mg + Atenolol 50mg Tab (Uncoated) is a tablet formulated with Amlodipine 5mg + Atenolol 50mg ( ). The listed active ingredient profile is Amlodipine; Atenolol, placing the product in the antihypertensive / cardiovascular category. The formulat
Tablet
Amlodipine 5mg + Telmisartan 40mg + Hydrochlorothiazide 12.5mg Tab (Film coated) is a tablet formulated with Amlodipine 5mg + Telmisartan 40mg + Hydrochlorothiazide 12.5mg ( ). The listed active ingredient profile is Amlodipine; Telmisartan; Hydrochloroth
Tablet
Amlodipine 5mg Tab Uncoated is a tablet formulated with Amlodipine 5mg. The listed active ingredient profile is Amlodipine, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardiovascular medicine
Tablet
Atorvastatin 10mg + Fenofibrate 160mg Tab. (Film coated) is a tablet formulated with Atorvastatin 10mg + Fenofibrate 160mg . ( ). The listed active ingredient profile is Atorvastatin; Fenofibrate, placing the product in the lipid-lowering therapy category
Tablet
Atorvastatin 10mg Tab. (Film Coated) is a tablet formulated with Atorvastatin 10mg . ( ). The listed active ingredient profile is Atorvastatin, placing the product in the lipid-lowering therapy category. The formulation contains lipid-lowering medicine(s)
Tablet
Atorvastatin 20mg Tab. (Film) is a tablet formulated with Atorvastatin 20mg . (Film). The listed active ingredient profile is Atorvastatin, placing the product in the lipid-lowering therapy category. The formulation contains lipid-lowering medicine(s) use
Tablet
Cilnidipine Tablets IP 5mg (Film coated) is a tablet formulated with Cilnidipine IP 5mg ( ). The listed active ingredient profile is Cilnidipine, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more c
Tablet
Ivabradine Hydrochloride 5mg Tab. (Film Coated) is a tablet formulated with Ivabradine Hydrochloride 5mg . ( ). The listed active ingredient profile is Ivabradine Hydrochloride, placing the product in the antianginal / cardiovascular category. The active
Tablet
Labetalol 100mg Tablets (Film coated) is a tablet formulated with Labetalol 100mg ( ). The listed active ingredient profile is Labetalol, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardiovas
Tablet
Metoprolol Succinate 50 mg(ER) + Telmisartan 40mg Tab. (Film Coated) is a tablet formulated with Metoprolol Succinate 50 mg(ER) + Telmisartan 40mg . ( ). The listed active ingredient profile is Metoprolol Succinate; Telmisartan, placing the product in the
Tablet
Metoprolol Succinate Prolonged Release Tablets IP 47.5 mg is a tablet formulated with Metoprolol Succinate IP 47.5 mg. The listed active ingredient profile is Metoprolol Succinate, placing the product in the antihypertensive / cardiovascular category. The
Tablet
Nebivolol 2.5mg + Cilnidipine 10mg Tablets (Film coated bilyered) is a tablet formulated with Nebivolol 2.5mg + Cilnidipine 10mg ( bilyered). The listed active ingredient profile is Nebivolol; Cilnidipine, placing the product in the antihypertensive / car
Tablet
Nebivolol Tablets IP 2.5MG (Uncoated) is a tablet formulated with Nebivolol IP 2.5MG ( ). The listed active ingredient profile is Nebivolol, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardio
Tablet
Olmesartan 20mg + Hydrochlorothiazide 12.5 Tab. (Film Coated) is a tablet formulated with Olmesartan 20mg + Hydrochlorothiazide 12.5 . ( ). The listed active ingredient profile is Olmesartan; Hydrochlorothiazide, placing the product in the antihypertensiv
Tablet
Olmesartan 40mg Tab. (Film Coated) is a tablet formulated with Olmesartan 40mg . ( ). The listed active ingredient profile is Olmesartan, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardiovas
Tablet
Olmesartan Medoxomil 20mg + Amlodipine Besylate 5mg Tab. (Film Coated) is a tablet formulated with Olmesartan Medoxomil 20mg + Amlodipine Besylate 5mg . ( ). The listed active ingredient profile is Olmesartan Medoxomil; Amlodipine Besylate, placing the pr
Tablet
Olmesartan Medoxomil 40mg + Hydrochlorothiazide 12.5mg Tab. (Filrn Coated) is a tablet formulated with Olmesartan Medoxomil 40mg + Hydrochlorothiazide 12.5mg . (Filrn Coated). The listed active ingredient profile is Olmesartan Medoxomil; Hydrochlorothiazi
Tablet
Olmesartan Medoxomil 40mg + Hydrochlorothiazide 25mg Tab. (Film Coated) is a tablet formulated with Olmesartan Medoxomil 40mg + Hydrochlorothiazide 25mg . ( ). The listed active ingredient profile is Olmesartan Medoxomil; Hydrochlorothiazide, placing the
Tablet
Olmesartan Medoxomil 40mg + Ramipril 5mg Tab. (Film Coated) is a tablet formulated with Olmesartan Medoxomil 40mg + Ramipril 5mg . ( ). The listed active ingredient profile is Olmesartan Medoxomil; Ramipril, placing the product in the antihypertensive / c
Tablet
Ramipril 2.5 mg Tab. Uncoated) is a tablet formulated with Ramipril 2.5 mg . ). The listed active ingredient profile is Ramipril . ), placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardiovascula
Tablet
Rivaroxaban 2.5mg Tablet (film coated) is a tablet formulated with Rivaroxaban 2.5mg ( ). The listed active ingredient profile is Rivaroxaban, placing the product in the anticoagulant category. The active medicine reduces blood-clot formation through anti
Tablet
Rosuvastatin 10 mg + Fenofibrate Tablets 160mg is a tablet formulated with Rosuvastatin 10 mg + Fenofibrate 160mg. The listed active ingredient profile is Rosuvastatin; Fenofibrate, placing the product in the lipid-lowering therapy category. The formulati
Capsule
Rosuvastatin 10mg + Aspirin 7Smg Capsules is a capsule formulated with Rosuvastatin 10mg + Aspirin 7Smg. The listed active ingredient profile is Rosuvastatin; Aspirin 7Smg, placing the product in the antiplatelet / lipid-lowering combination category. The
Capsule
Rosuvastatin 10mg + Clopidogrel 75mg Capsules is a capsule formulated with Rosuvastatin 10mg + Clopidogrel 75mg. The listed active ingredient profile is Rosuvastatin; Clopidogrel, placing the product in the antiplatelet / lipid-lowering combination catego
Tablet
Rosuvastatin 10mg Tab. (Film Coated) is a tablet formulated with Rosuvastatin 10mg . ( ). The listed active ingredient profile is Rosuvastatin, placing the product in the lipid-lowering therapy category. The formulation contains lipid-lowering medicine(s)
GMP Certified Manufacturers
Wide Product Portfolio
Multiple Dosage Forms
Global Supply Network
Regulatory Documentation
Competitive PricingOur sourcing experts are ready to help with custom requirements, supply availability and regulatory documentation.
